SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-22-000029
Filing Date
2022-05-10
Accepted
2022-05-09 18:04:57
Documents
93
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20220331x10q.htm   iXBRL 10-Q 2109273
2 EX-31.1 amph-20220331xex31d1.htm EX-31.1 19163
3 EX-31.2 amph-20220331xex31d2.htm EX-31.2 18818
4 EX-32.1 amph-20220331xex32d1.htm EX-32.1 9832
5 EX-32.2 amph-20220331xex32d2.htm EX-32.2 9833
  Complete submission text file 0001297184-22-000029.txt   9485039

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20220331.xsd EX-101.SCH 58229
7 EX-101.CAL amph-20220331_cal.xml EX-101.CAL 64255
8 EX-101.DEF amph-20220331_def.xml EX-101.DEF 268049
9 EX-101.LAB amph-20220331_lab.xml EX-101.LAB 461738
10 EX-101.PRE amph-20220331_pre.xml EX-101.PRE 431951
87 EXTRACTED XBRL INSTANCE DOCUMENT amph-20220331x10q_htm.xml XML 1931071
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 22906508
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences